It is a chemicals private limited company based in Lucknow, Uttar Pradesh, India, established in 2012.
2012 | Lucknow, Uttar Pradesh, India | ActiveFour Seasons Pharmaceuticals Private Limited, a active private limited company, was established on 04 April 2012 in Lucknow, Uttar Pradesh, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U33111UP2012PTC049721. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.25 M.
It upholds a compliant status. Employing 18 professional, Its leadership includes Jaspal Singh Parmar (Director), Meenu Parmar (Director). Past directors included Mala Nayyar, Tribhuwan Das, Vaibhav Rastogi. It holds ₹1.07 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-207 Transport Nagar, Lucknow, Uttar Pradesh, 226012.
U33111UP2012PTC049721
049721
04 April 2012
₹3.00 M
₹2.25 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Four Seasons Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaspal Singh Parmar | Director | 04 Nov 2019 | Current |
| Meenu Parmar | Director | 04 Apr 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 May 2019 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Four Seasons Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Four Seasons Pharmaceuticals had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,074,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2021 | Hdfc Bank Limited | ₹1.07 M | Open |
Explore comprehensive loan charge details -
Four Seasons Pharmaceuticals has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Four Seasons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Four Seasons Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Four Seasons Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Four Seasons Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.07 M with Charge ID 100472860 was registered on 02 Jul 2021. was completed.
The activity Jaspal Singh Parmar was appointed as a Director was appointed as a Director on 04 Nov 2019 & has been associated with this company since 6 years 27 days . was completed.
Progress on Meenu Parmar was appointed as a Director was appointed as a Director on 04 Apr 2012 & has been associated with this company since 13 years 7 months . was documented.
The activity Four Seasons Pharmaceuticals Private Limited was registered on 04 Apr 2012 with Roc Kanpur & aged 13 years 7 months as per MCA records. was completed.
The CIN of Four Seasons Pharmaceuticals Private Limited is U33111UP2012PTC049721.
Four Seasons Pharmaceuticals Private Limited is headquartered at E-207 Transport Nagar, Lucknow, Uttar Pradesh, 226012.
Four Seasons Pharmaceuticals Private Limited was incorporated on 04 April 2012.
The current directors of Four Seasons Pharmaceuticals Private Limited are
The primary industry of Four Seasons Pharmaceuticals Private Limited is Manufacturing.
Four Seasons Pharmaceuticals Private Limited is unlisted.
The authorized capital of Four Seasons Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹2.25 M.
The compliance status of Four Seasons Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX